Antisense & RNAi Therapeutics: Pioneering Precision Medicine...

أضاف وظيفة جديدة Iniciativas de Impacto

2026-09-30 06:11:50 -

Antisense & RNAi Therapeutics: Pioneering Precision Medicine Through Gene Silencing

The Antisense & Rnai Therapeutics Market was valued at USD 6.7 billion in 2025 and is projected to grow to USD 16 billion by 2035, registering a CAGR of 9.1% during the forecast period. This remarkable growth trajectory reflects the fundamental role of antisense and RNAi therapeutics in addressing the demand for targeted treatments, improved patient outcomes, and innovative therapeutic...

0 التعليقات 0 المشاركات 0 معاينة